Group sequential designs for negative binomial outcomes.


Journal

Statistical methods in medical research
ISSN: 1477-0334
Titre abrégé: Stat Methods Med Res
Pays: England
ID NLM: 9212457

Informations de publication

Date de publication:
08 2019
Historique:
pubmed: 18 5 2018
medline: 28 10 2020
entrez: 18 5 2018
Statut: ppublish

Résumé

Count data and recurrent events in clinical trials, such as the number of lesions in magnetic resonance imaging in multiple sclerosis, the number of relapses in multiple sclerosis, the number of hospitalizations in heart failure, and the number of exacerbations in asthma or in chronic obstructive pulmonary disease (COPD) are often modeled by negative binomial distributions. In this manuscript, we study planning and analyzing clinical trials with group sequential designs for negative binomial outcomes. We propose a group sequential testing procedure for negative binomial outcomes based on Wald statistics using maximum likelihood estimators. The asymptotic distribution of the proposed group sequential test statistics is derived. The finite sample size properties of the proposed group sequential test for negative binomial outcomes and the methods for planning the respective clinical trials are assessed in a simulation study. The simulation scenarios are motivated by clinical trials in chronic heart failure and relapsing multiple sclerosis, which cover a wide range of practically relevant settings. Our research assures that the asymptotic normal theory of group sequential designs can be applied to negative binomial outcomes when the hypotheses are tested using Wald statistics and maximum likelihood estimators. We also propose two methods, one based on Student's

Identifiants

pubmed: 29770729
doi: 10.1177/0962280218773115
doi:

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

2326-2347

Auteurs

Tobias Mütze (T)

1 Department of Medical Statistics, University Medical Center Göttingen, Göttingen, Germany.

Ekkehard Glimm (E)

2 Statistical Methodology, Novartis Pharma AG, Basel, Switzerland.
3 Medical Faculty, Institute for Biometrics and Medical Informatics, Otto-von-Guericke-University Magdeburg, Magdeburg, Germany.

Heinz Schmidli (H)

2 Statistical Methodology, Novartis Pharma AG, Basel, Switzerland.

Tim Friede (T)

1 Department of Medical Statistics, University Medical Center Göttingen, Göttingen, Germany.
4 DZHK (German Centre for Cardiovascular Research), partner site Göttingen, Göttingen, Germany.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH